Asenapine
Related Experiment Video
Updated: Jun 19, 2026

Transesophageal Atrial Burst Pacing for Atrial Fibrillation Induction in Rats
Published on: February 14, 2022
Herbert Y Meltzer1, Argyris Dritselis, Uma Yasothan
1Herbert Y. Meltzer is at Vanderbilt University School of Medicine, Nashville, Tennessee 32712, USA. herbert.meltzer@vanderbilt.edu
Abstract:
In August 2009, asenapine (Saphris; Schering-Plough) was approved by the US FDA for the acute treatment of schizophrenia and manic or mixed episodes associated with bipolar I disorder in adults.
Related Concept Videos
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
Antiepileptic Drugs: GABAergic Pathway Potentiators
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
Antiepileptic Drugs: Glutamate Antagonists
Parenteral Anesthetics: Overview
Anxiolytic Drugs: Benzodiazepines and Buspirone
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
